2012 Health Expenditure and Pharma Forecast Report
Amid the current global economic slowdown and financial-market turbulence, this report from IHS looks at the recent economic and healthcare policy developments in selected major economies.
The report examines the impact of these developments on health expenditure and pharma sales, and forecasts growth in healthcare spending in 2012.
Report topics include:
- Total health spending growth in developed Vs emerging Markets
- Planned US medicare payment cuts
- P&R cuts in France
- Price cuts and high generic penetration in Germany
- Increasing UK public health expenditure and improved access to medicines
- Italy's austerity measures
- Spain's deficit reduction and cost-containment measures
- Cost-containment measures in Czech Republic, Hungary and Slovakia
- China's healthcare reform
- India's health-insurance coverage expansion and price controls
- Brazil's rising domestic drug production and lowered drug prices
IHS World Markets Healthcare Forecasting Service
This report was first published in October 2011 as part of the World Markets Healthcare Forecasting Service. The service provides a clear view of healthcare markets, their key drivers, and the market impact of key events. Featuring macroeconomic forecasts, health expenditure forecasts for 36 countries, and pharma sales forecasts for 30 countries and 11 therapeutic areas, the service provides the tools you need to quantify future market growth. More
